proteolysis is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Updated 2026-03-29. Numbers and descriptions here follow the published literature rather than marketing material.
Measuring peptide exposure inside the brain is technically difficult. Selank is degraded rapidly in plasma, and assays must separate intact peptide from fragments, which favors targeted mass spectrometry over immunoassays alone. Reported half-lives are short, on the order of minutes, so effects observed hours later are attributed to downstream signaling rather than to the parent compound. Blood-brain barrier permeability is debated and rarely quantified directly. Gaps include absent dose-response characterization, inconsistent reporting of purity, and almost no pharmacokinetic data from human participants.
Selank is studied chiefly as an animal-model anxiolytic with proposed secondary effects on memory and immune signaling. Reported mechanisms include modulation of the GABA-A receptor complex, inhibition of enkephalin-degrading enzymes, and shifts in monoamine turnover within limbic structures. Some experiments describe increased expression of brain-derived neurotrophic factor in the hippocampus after repeated dosing. No single molecular target has been confirmed, and the peptide does not bind any receptor with the selectivity typical of a conventional small-molecule drug. Mechanism therefore remains a set of hypotheses rather than an established pathway.
Laboratory work relies on standard behavioral paradigms. Rodents are tested in the elevated plus maze, open field, and passive avoidance tasks, with outcomes compared against diazepam or vehicle controls. Intranasal dosing is used most often because it bypasses first-pass metabolism, though intraperitoneal and intravenous routes also appear in published protocols. Biochemical endpoints include tissue BDNF concentrations, cytokine levels, and monoamine metabolites. Human data are limited to small Russian trials reporting reduced anxiety scores; most were not prospectively registered, and few employed independent outcome assessment.
Pharmacokinetic data are limited. Like most short peptides, Selank is vulnerable to plasma and tissue peptidases, and its measured half-life in circulation is short, on a minutes scale. The Pro-Gly-Pro tail slows this degradation but does not eliminate it. Intranasal administration is the route described in most reports, with absorption through the nasal mucosa and a hypothesized path into the central nervous system that avoids the blood-brain barrier. Direct measurements of human brain exposure are unavailable, so distribution claims rest on inference from animal work.
Clinical evidence comes mainly from small studies conducted in Russia, several of which were open-label or lacked robust blinding. Reported outcomes include lower anxiety scores, changes in attention measures, and effects on asthenic states following illness. Sample sizes are typically in the tens of participants, and independent replication outside the region is scarce. Reviews published in English generally note the limited methodological quality of the underlying trials. Whether the compound produces clinically meaningful effects under rigorous conditions remains unresolved.
| Property | Value | Notes |
|---|---|---|
| Principal proposed target | GABA-A receptor complex | Hypothesis derived mainly from animal pharmacology |
| Common behavioral assay | Elevated plus maze | Rodent test for anxiety-like behavior |
| Reported molecular marker | Hippocampal BDNF expression | Measured by immunoassay or mRNA quantification |
| Typical dosing route | Intranasal | Chosen to reduce first-pass metabolism |
| Reported plasma half-life | Minutes | Based on limited peptide stability data |
Outside its country of origin the compound is generally handled as a research chemical rather than an approved medicine. No regulatory approval from the United States Food and Drug Administration or the European Medicines Agency has been granted for human use. Identity and purity are normally checked by reverse-phase high-performance liquid chromatography, with mass spectrometry used to confirm the molecular mass. Lyophilised material is stored cold and desiccated, and repeated freeze-thaw cycles are avoided.
Published work on this peptide almost always uses intranasal delivery, with drops or a spray applied to the nasal mucosa. Some animal experiments have used subcutaneous or intraperitoneal injection, and a smaller number have compared routes directly. Oral administration is not a focus of the literature, because short peptides of this size are broken down by digestive enzymes and cross intestinal barriers poorly. How much of an intranasal dose reaches the bloodstream intact in humans remains an open question.
Peptide bonds are vulnerable to protease attack, and Selank is no exception. Measured half-life in serum is short, on the order of minutes in several reports, which explains why intranasal administration is the common route described in the literature. Absorption across the nasal mucosa partially bypasses first-pass hepatic metabolism. Quantitative data on human bioavailability remain limited and are difficult to compare across studies.
Lyophilised material kept dry at minus 20 degrees Celsius or colder is the most stable form, and suppliers commonly state a shelf life of two years or more under those conditions. Once dissolved, degradation accelerates through hydrolysis and deamidation, particularly at alkaline pH or elevated temperature. Working solutions are usually divided into single-use aliquots to avoid repeated freeze-thaw cycles. The choice of reconstitution solvent affects both stability and the ionic strength of the final preparation.
Former CMC chairman Jiang in 1990 called on the military to "meet political standards, be militarily competent, have a good working style, adhere strictly to discipline, and provide vigorous logistic support" (Chinese: 政治合格、军事过硬、作风优良、纪律严明、保障有力; pinyin: zhèngzhì hégé, jūnshì guòyìng, zuòfēng yōuliáng, jìlǜ yánmíng, bǎozhàng yǒulì). The 1991 Gulf War provided the Chinese leadership with a stark realization that the PLA was an oversized, almost-obsolete force. The USA's sending of two aircraft carrier groups to the vicinity of Taiwan during the Third Taiwan Strait Crisis prompted Jiang to order a ten-year PLA modernization program.
== Regulation of sulfur assimilation == Sulfur assimilation is highly regulated and influenced by both external environmental factors and internal metabolic feedback pathways, in order to maintain sulfur homeostasis. Under sulfur-deficient conditions, plants modify their internal pathways to enhance sulfur uptake. In plants, a key regulator is the transcription factor SLIM1 (Sulfur Limitation 1), which functions in activating genes involved in sulfur transport like SULTR1;2 (a high-affinity transporter) and those involved in sulfur assimilation like ATP sulfurylase and APS reductase. The post-transcriptional regulation of these genes are done via a microRNA called miR395. When sulfur uptake is sufficient and is no longer limited, this microRNA targets the SULTR2;1(a low-affinity transporter) and degrades/inhibits its translation. Besides the transcriptional regulation of sulfur assimilation, there also lies post-translational mechanisms that control this process. This includes feedback inhibition by the accumulation of end products such as glutathione and cysteine, as well as regulation of the enzyme APS reductase which is activated or inhibited by the redox state of the cell. In fungi, specifically the Aspergillus fumigatus, sulfur assimilation is managed by the transcription factor MetR. This transcription factor functions similarly to SLIM1, in which under sulfur-limiting conditions it activates genes responsible for sulfur uptake. MetR also plays a key role in protecting the fungus's virulence against the host-immune system.
ATC code D Dermatologicals is a section of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products. Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QD. ATCvet codes without corresponding human ATC codes are cited with the leading Q in the following list.National versions of the ATC classification may include additional codes not present in this list, which follows the WHO version.
== Corporate culture == S. Truett Cathy was a devout Southern Baptist; his religious beliefs had a major impact on the company. The company's official statement of corporate purpose says that the business exists "To glorify God by being a faithful steward of all that is entrusted to us. To have a positive influence on all who come in contact with Chick-fil-A." Cathy opposed the company becoming public for religious and personal reasons. A company spokesperson said in 2012, "The Chick-fil-A culture and service tradition in our Restaurants is to treat every person with honor, dignity, and respect –regardless of their belief, race, creed, sexual orientation, or gender."
Sources: en.wikipedia.org
=== Pharmacodynamics === Oxa-noribogaine acts as an atypical κ-opioid receptor (KOR) partial agonist similarly to noribogaine but shows dramatically increased potency and selectivity compared to noribogaine (EC50Tooltip half-maximal effective concentration = 43 nM vs. 6,100 nM, respectively; 142-fold difference). It produces analgesic effects in animals, but unlike conventional KOR agonists, does not produce aversive or pro-depressive effects. The drug induces a robust KOR-dependent increase in GDNF levels in the ventral tegmental area (VTA) and medial prefrontal cortex (mPFC). After a single dose or short-term treatment, oxa-noribogaine induces long-lasting suppression of opioid drug-seeking behavior in rodent relapse models. It also counteracts persistent opioid-induced hyperalgesia. In addition, oxa-noribogaine decreases alcohol consumption in rodents.
These properties of the two sub-units, allow the opioid receptor's G protein to permanently interact with the membrane via lipid anchors. When an agonistic ligand binds to the opioid receptor, a conformational change occurs, and the GDP molecule is released from the Gα sub-unit. This mechanism is complex, and is a major stage of the signal transduction pathway. When the GDP molecule is attached, the Gα sub-unit is in its inactive state, and the nucleotide-binding pocket is closed off inside the protein complex. However, upon ligand binding, the receptor switches to an active conformation, and this is driven by intermolecular rearrangement between the trans-membrane helices. The receptor activation releases an 'ionic lock' which holds together the cytoplasmic sides of transmembrane helices three and six, causing them to rotate. This conformational change exposes the intracellular receptor domains at the cytosolic side, which further leads to the activation of the G protein. When the GDP molecule dissociates from the Gα sub-unit, a GTP molecule binds to the free nucleotide-binding pocket, and the G protein becomes active. A Gα(GTP) complex is formed, which has a weaker affinity for the Gβγ sub-unit than the Gα(GDP) complex, causing the Gα sub-unit to separate from the Gβγ sub-unit, forming two sections of the G protein. The sub-units are now free to interact with effector proteins; however, they are still attached to the plasma membrane by lipid anchors.
== Properties == In 1969, strong piezoelectricity was observed in PVDF, with the piezoelectric coefficient of poled (placed under a strong electric field to induce a net dipole moment) thin films as large as 6–7 pC/N: 10 times larger than that observed in any other polymer. PVDF has a glass transition temperature (Tg) of about −35 °C and is typically 50–60% crystalline. To give the material its piezoelectric properties, it is mechanically stretched to orient the molecular chains and then poled under tension. PVDF exists in several phases depending on the chain conformations as trans (T) or gauche (G) linkages: TGTG' for α and δ phase, TTTT for β phases, and TTTGTTTG' for γ and ε phases. The α and ε conformations lack piezoelectric properties because of the antiparallel alignment of dipoles within its unit cell. The β, γ, and δ phases feature a parallel arrangement of dipoles, rendering them polar crystals with a non-zero dipole moment. Among these phases, the β phase stands out due to its remarkable remnant polarization and the highest dipolar moment per unit cell, garnering more interest compared to the others. When poled, PVDF is a ferroelectric polymer, exhibiting efficient piezoelectric and pyroelectric properties. These characteristics make it useful in sensor and battery applications. Thin films of PVDF are used in some newer thermal camera sensors. Unlike other popular piezoelectric materials, such as lead zirconate titanate (PZT), PVDF has a negative d33 value.
== History == The discovery and characterization of aminopeptidases date back to the early 20th century. The term "aminopeptidase" was first introduced in 1929 by Linderstrøm-Lang and Sato in order to describe enzymes that cleave amino acids from the N-terminus of peptides. In the 1950s and 1960s, the discovery of leucine aminopeptidase (LAP) and aminopeptidase N (APN) marked important milestones in the field. LAP was found to be crucial for protein digestion, while APN was recognized for its role in the regulation of peptide-mediated effects. These discoveries were pivotal in understanding the physiological functions of aminopeptidases and their involvement in health and disease. The subsequent decades saw extensive research into the structure, function, and mechanisms of action of various aminopeptidases. For example, the M1 family of aminopeptidases, which includes puromycin-sensitive aminopeptidase (PSA), was characterized by conserved zinc-dependent sites and exopeptidase motifs. The study of PSA in different model organisms revealed its essential roles in growth and behavior. Mutations in orthologs of PSA in different species were linked to errors in meiosis and reduced viability of embryos. Aminopeptidase N, also known as AP-N or CD13, was extensively characterized for its broad substrate specificity (ability to bind to its targets) and its presence in various tissues such as the brush border membranes of the kidney, small intestine, and placenta.
The opposite property to ionisation energy is the electron affinity, which is the energy released when adding an electron to the atom. A passing electron will be more readily attracted to an atom if it feels the pull of the nucleus more strongly, and especially if there is an available partially filled outer orbital that can accommodate it. Therefore, electron affinity tends to increase down to up and left to right. The exception is the last column, the noble gases, which have a full shell and have no room for another electron. This gives the halogens in the next-to-last column the highest electron affinities. Some atoms, like the noble gases, have no electron affinity: they cannot form stable gas-phase anions. (They can form metastable resonances if the incoming electron arrives with enough kinetic energy, but these inevitably and rapidly autodetach: for example, the lifetime of the most long-lived He− level is about 359 microseconds.) The noble gases, having high ionisation energies and no electron affinity, have little inclination towards gaining or losing electrons and are generally unreactive. Some exceptions to the trends occur: oxygen and fluorine have lower electron affinities than their heavier homologues sulfur and chlorine, because they are small atoms and hence the newly added electron would experience significant repulsion from the already present ones. For the nonmetallic elements, electron affinity likewise somewhat correlates with reactivity, but not perfectly since other factors are involved.
Sources: en.wikipedia.org
Intranasal administration predominates in both animal and human research because it avoids hepatic first-pass metabolism. Injectable and intraperitoneal routes appear in animal work mainly for comparison.
Behavioral endpoints include time spent in open arms of the elevated plus maze and avoidance latencies. Biochemical endpoints include BDNF concentration, cytokine levels, and monoamine metabolite ratios in brain tissue.
Most published studies are small, originate from a limited number of laboratories, and lack independent replication. Dose-response relationships, measured brain exposure, and long-term outcomes are not well characterized.
Reports describe effects on GABA-A receptor expression, monoamine turnover, and neurotrophic factor levels. These are proposed mechanisms drawn mainly from animal models. No single molecular target has been established.